psycho pharmacology ii 13 juni

Upload: irisfirdauz

Post on 14-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    1/18

    BYDr. Wayan Westa, SpKJ(K)

    Dept Of Psychiatry Faculty of Medicine Udayana University/Sanglah Hospital Denpasar

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    2/18

    THERAPY

    BIOLOGICAL THERAPY

    DRUG THERAPY ELECTRO CONPULSIVE THERAPY SURGICAL THERAPY

    PSYCHO THERAPY

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    3/18

    1. Benzodiazephine Receptor Agonists and

    Antagonists2. Dopamine Receptor Antagonists (Typical

    Anti Psychotic)

    3. Serotonin Dopamine Antagonists (Atypical

    Antipsychotic)4. Tricyclic and Tetracyclic

    5. Selective Serotonin Reuptake Inhibitor (SSRI)

    6. Selective Serotonin NorepinephrineReuptake Inhibitors (SSNRI)

    7. Lithium

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    4/18

    as sedative hypnotic, althrough other drugs can alsobe classified in this group BarbuturatesBenzodiazepine enchane the activity of the GABAReceptor1. Diazepam (Valium)

    2. Lorazepam (Ativan)3. Alprazolam (Xanax)4. Estazolam (Esilgan)5. Clorazepate (Tranxene)6. Clobazam (Frizium)

    7. Clonazepam (Riklona)8. EtcBenzodiazepine are drugs of choice for management ofacute anxiety and agitation

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    5/18

    1. Generalized anxiety disorders, adjusmentdisorders

    2. Mixed anxiety Depressive Disorders

    3. Panic Disorders and Social Phobia :

    4. Obsessive Compulsive Disorders5. Postraumatic Stress Disorders

    6. Insomnia

    7. Bipolar I Disorders (Mania)8. Akathisia

    9. Parkinson deseases

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    6/18

    Anxiety, Irritability, Insomnia, ConcentrationDifficultis, Depression, Depersonalization,Increased Sensory Perception, Derealization.

    Fatigue, Headace, Muscle Twitching,Sweating, Dizzines, Nausea,

    When benzodiazepine are used for shortperiods 1 2 weeks

    Benzodiazepine Receptor Antagonist :Flumazenil used to overdosage ofBenzodiazepine.

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    7/18

    Treatment for : Schizophrenia and other psychoticdisorders.Include : Chlorpromazine (Promactil), Thioridazine(Melleril) Haloperidol (Haldol) Trifluoperazine(Stelazine) Fluphenazine (Anatenzol). Also called

    typical antipsychosisA new class of antipsychotic agent : The Serotonin Dopamine Antagonist (SDAs)Also called : Atypical anti psychosis : Risperidon(Risperdal) Clozapine (Clozaril) Quetiapine

    (Seroquell) Olanzapine (Zyprexa) Ziprasidone,Aripifrazole (Abilify) which has fewer Neurologicalside effect

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    8/18

    1. Primary Psychotic Disorders2. Schizophrenia3. Bipolar Disorders4. Secondary Psychosis Organic Cause5. Severe Agitation and Violent Behavior6. Tourettes Disorders7. Other Psychiatric and Non Psychiatric Indication- Anxiety- Nausea- Emesis- Hiccups- Proritus- Ballismus

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    9/18

    1. Non Neurologicala. Cardiac effects prolong QT and PR Internal

    Suddent Deathb. Orthostatic/postural hypotensionc. Hematological effect : Leucopenia, agranulocytosisd. Periferal anticholinergic effect : dry mouth, nausea,

    vomiting, blurred vision, constipation urinaryretention, mydriasis pupil

    e. Endocrine effect : galactorrhea, amenorrhea,impotence, inhibited Orgasm in women. Sexualadverse effects impotence treated with sildenafil

    (viagra)f. Weight gaing. Dermatological effect pigmentation in retinah. Cholestatic jaundice

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    10/18

    2. Neurological effects :

    a. Parkinsonism Tremor, Rigiditytreated with anticholinergic agents :Benztropine, (Cogentin) amantadine(Symmetrel) diphenhidramin (Benadryl)

    b. Acute Dystonia : torticolis spasmodic,oculogyric crisisc. Acute Akathisia Restlegsless syrodromesd. Tardive dyskinesia

    e. Neuroleptic Malignan Syndromes

    f. Epileptogenic effect

    g. Sedation

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    11/18

    Tricyclic and Tetracyclic Antidepressantstreatment for :

    1. Major depressive Disorder2. Mood disorder due to a general medical

    condition (secondary Depression)3. Panic disorder with agoraphobia

    4. Generalized anxiety disorder5. Obsessive compulcive disorder6. Post traumatic stress disorders7. Eating disorder anorexia nervosa, bulimia

    nervosa8. Pain disorder9. Childhood Enuresis

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    12/18

    1. Psychiatric effect : Inducing Maniac episode2. Anticholinergic effect : dry mouth, constipation,

    blurred vision, urinary retention3. Sedation : effect anti histamin4. Autonomic effect : Ortostatic hypotension because

    an adrenergic blockade5. Cordiac effect : prolong QT internal, depressed ST,

    flattenal T Waves6. Neurological : myoclonic, ataxia, tremor7. Dermatological effect: Allergic, Exanthematous

    Rashes, agranulositosis8. Wight gain : because blockade of histamine 2 (H2).

    Impotence blockade dopamine receptor in tuberoinfundibular tract

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    13/18

    First line agents for treatment of : Depression, Obsesive Compulsive Disorder, PanicDisorder.SSRIs included : Fluoxetin (Prozac), Sertraline (Zoloft), Paroxetine (Paxil), Fluvoxamine

    (Luvox), Citalopram (Celexa).Therapiute Indications1. Depression2. Suicide3. Depression during pregnancy

    4. Depression in the ederly and medically ill5. Chronic depression6. Depression in children

    7. Anxiety disorders OCD, Panic, Social Phobia, PTSD, Bulimia, Anorexia, Obesity8. Premenstrual dysphoric disorders9. Premature ejaculation

    10. Paraphilia comorbid with depression11. Autistic Disorders12. Attention deficit hyperactive Disorder13. Chronic pain Syndromes14. Psikosomatic Conditions

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    14/18

    1. Sexual disfunction inhibited Orgasm2. Gastrointestinal adverse effect nausea,

    dearhea, anorexia, vomiting3. Weight gain

    4. Headaches5. CNS adverse effect anxiety, insomnia, severe

    vivid dream, nightmare6. Anticholinergic effect : dry mouth, constipation.

    Extrapyramidal symptoms : tremor, akatisia

    7. Serotonin syndromes : tremor, dearhea, atoxia,myoclonus, hyperthermia, delirium, statusepileticus, coma

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    15/18

    Inhibiting degradation of biogenic amines : serotonine, dopamine,norapinephrine. But less frequently used because of the dietory

    precuations that must be followed to used avoid tyramine. Inducedhypertensive crisis. MAOIs include : phenelzine (Nardil) isocarboxazid(Marplan) tranylcypromine (parnate), selegiline (Eldepryl)

    Therapuitic Indication1. Depression characteristic by hypersomnia, hyperphagia, anxiety2. Panic with Agoraphobia, Posttraumatic disorder, eating disorder, social

    phobia, pain disorder

    Precaution and Adverse Reaction1. Orthostatic hypotensia2. Insomnia3. Weight gain4. Oedem5. Sexual disfunction6.

    Tyramine induced hypertensive crisis7. Withdrawal : mood desturbances, somatic symptom8. Overdosis : Agitasi, hypertermia, comaReversible Inhibitors Mono Amine Oxidase (RIMAs) Moclobemide

    (Aurorix)

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    16/18

    Venlafaxine (Effexor) is an effectiveantidepressant drug that may have a fasteronset of action than other antidepressantdrugs when the dosage is increased rapidly.

    Venlafaxine is potent inhibitor of serotoninand norepinephrine and weak inhibitor ofDopamine reuptake

    Duloxetine (Cymbalta)

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    17/18

    1. Depressions with melancholic features2. Generalized anxiety disorder3. Obsessive compulsive disorder,

    Phobia,ADHDChronic pain syndromes

    Precaution and adverse ReactionsThe most cammon reaction are : nausea,

    somnolence, dry mouth, dizzines, nervousness,constipation, asthenia, anxiety, anorexia, blurredvision, abnormal ejaculation and orgasm

  • 7/29/2019 Psycho Pharmacology II 13 Juni

    18/18